Moolec Science (MLEC) Treasury Shares (2023 - 2025)

Moolec Science (MLEC) reported Treasury Shares of -$1232.0 for Q4 2024, little changed sequentially from -$1232.0 in Q3 2024.

Moolec Science (MLEC) Treasury Shares (2023 - 2025) Analysis & Trends

Moolec Science (MLEC) has 2 years of Treasury Shares data on file, last reported at -$1232.0 in Q4 2024.

For the quarter ending Q4 2024, Treasury Shares changed N/A year-over-year to -$1232.0; the trailing twelve-month figure through Dec 2024 stood at -$1232.0 (changed N/A YoY), and the FY2024 full-year result was -$1232.0, changed N/A from the prior year.
Treasury Shares advanced to -$1029.0 in Q4 2025, from -$422146.0 in the prior quarter.
In the past five years, Treasury Shares ranged from a high of $60083.0 in Q2 2024 to a low of -$422146.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-21,709.08
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	265,401.92
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	19.41 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	5.14 Mn
10	Moolec Science	5.21 Bn	5.21 Bn	-	-

Download Data